| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 08/06/1997 | EP0787196A1 Dna sequence and its use |
| 08/06/1997 | EP0787191A2 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
| 08/06/1997 | EP0787190A2 Hepatitis e virus antigens and uses therefor |
| 08/06/1997 | EP0787184A1 Recombinant alternaria alternata allergens |
| 08/06/1997 | EP0787149A1 POLYNUCLEOTIDE ENCODING C5a RECEPTOR |
| 08/06/1997 | EP0787144A1 Major outer membrane protein cd of moraxella |
| 08/06/1997 | EP0787136A1 Novel opacity associated proteins, dna encoding the same, and methods of use thereof |
| 08/06/1997 | EP0787121A1 Legionella specific antibiotic, a microorganism producing the antibiotic and a process for producing the same |
| 08/06/1997 | EP0787013A1 Human hypoxanthine-(guanine) phosphoribosyl transferase-2 |
| 08/06/1997 | EP0787012A1 Suppression of proteolytic activity by dysfunctional protease formation |
| 08/06/1997 | EP0672175A4 Hav probes for use in solution phase sandwich hybridization assays. |
| 08/06/1997 | EP0610176B1 Degradation of ferric chelates by a pure culture of agrobacterium sp. |
| 08/06/1997 | EP0548070B1 Monoclonal antibody for differentiation of squamous cell carcinoma antigens and method of use for same |
| 08/06/1997 | EP0512997B1 Process for the heterotrophic production of products with high concentrations of omega-3 highly unsaturated fatty acids |
| 08/06/1997 | EP0502845B1 Human high-affinity neurotransmitter uptake system |
| 08/06/1997 | EP0368857B1 Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms |
| 08/06/1997 | CN1156482A Thermophilic fungal expression system |
| 08/06/1997 | CN1156480A Novel deaminoneuraminidase and process for producing same |
| 08/05/1997 | US5654405 Detection and purification of kgf; treating excessive epithelial cell growth; skin disorders, e.g., psoriasis; antitumor and carcinogenic agents |
| 08/05/1997 | US5654271 Fungicidally active compounds |
| 08/05/1997 | US5654181 Mutant of Geotrichum candidum which produces novel enzyme system to selectively hydrolyze triglycerides |
| 08/05/1997 | US5654158 Methods for detection of nephropathy-related immunoglobulin G using monoclonal antibodies specific for nephropathy-related immunoglobulin G |
| 08/05/1997 | US5654146 Human ice homolog |
| 08/05/1997 | US5654145 Trophinin and trophinin-assisting nucleic acids and methods of detection thereof |
| 08/05/1997 | US5654139 Isolated dna sequence coding for allelic variation of serotonin 5-ht2c receptor having serine at position 23 instead of cysteine |
| 08/05/1997 | US5653980 For immunoglobulin e mediated allergies |
| 08/05/1997 | US5653975 Implanting encapsulated cells capable of producing human growth factor or trophic factor for diffusion into the central nervous system; treatment of diabetes; anemia; hypoparathyroidism; parkinson's and alzheimer's disease |
| 08/05/1997 | CA2008824C Method for the production of glucagon |
| 08/05/1997 | CA1339210C Recombinant techniques for production of novel natriuretic and vasodilator peptides |
| 08/05/1997 | CA1339209C Site selective genomic modification of yeast of the genus pichia |
| 08/05/1997 | CA1339208C Fusion proteins containing a hinge region for enhanced cleavage |
| 08/05/1997 | CA1339204C Mucin core polypeptide, antibodies and probes |
| 08/05/1997 | CA1339202C Method for preparing monoclonal antibody to hepatitis b surface antigen |
| 08/05/1997 | CA1339201C Chimera monoclonal antibody and a production process thereof |
| 08/05/1997 | CA1339198C Antibodies to the antigen campath-1 |
| 08/05/1997 | CA1339193C Human rhinovirus receptor protein that inhibits virus infectivity |
| 07/31/1997 | WO1997027485A1 Method for detecting anti-gadii antibody and method for diagnosing cancer using said detection method |
| 07/31/1997 | WO1997027334A1 Methods for identifying inhibitors of rna viruses |
| 07/31/1997 | WO1997027319A1 Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
| 07/31/1997 | WO1997027313A1 Cold-active protease cp70 |
| 07/31/1997 | WO1997027305A1 Production of bacillus thuringiensis integrants |
| 07/31/1997 | WO1997027300A1 TOXOPLASMA GONDII ANTIGEN Tg20 |
| 07/31/1997 | WO1997027296A1 Nucleic acids and proteins related to alzheimer's disease, and uses therefor |
| 07/31/1997 | WO1997027285A1 Cloned plant p-hydroxyphenyl pyruvic acid dioxygenase |
| 07/31/1997 | WO1997027276A2 Nucleic acids encoding polypeptides having absidia lipase activity |
| 07/31/1997 | WO1997027213A1 Methods for screening for transdominant effector peptides and rna molecules |
| 07/31/1997 | WO1997027212A1 Methods for screening for transdominant intracellular effector peptides and rna molecules |
| 07/31/1997 | WO1997027208A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 07/31/1997 | WO1997026903A1 Microencapsulated genetically engineered microorganisms for clinical application |
| 07/31/1997 | WO1997026853A2 Dna encoding galanin galr2 receptors and uses thereof |
| 07/31/1997 | CA2244373A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 07/31/1997 | CA2244372A1 Methods for identifying inhibitors of rna viruses |
| 07/31/1997 | CA2244222A1 Methods for screening for transdominant effector peptides and rna molecules |
| 07/31/1997 | CA2242200A1 Toxoplasma gondii antigen tg20 |
| 07/31/1997 | CA2216227A1 Dna encoding galanin galr2 receptors and uses thereof |
| 07/30/1997 | EP0786521A1 Nucleic acid encoding PspA |
| 07/30/1997 | EP0786520A1 Method for the production of biological active beta-NGF by genetic engineering |
| 07/30/1997 | EP0786519A2 Staphylococcus aureus polynucleotides and sequences |
| 07/30/1997 | EP0786518A1 Streptococcus equi vaccine |
| 07/30/1997 | EP0786474A1 A recombinant buman factor VIII derivative |
| 07/30/1997 | EP0786472A1 Vaccines and diagnostic assays for Haemophilus influenzae |
| 07/30/1997 | EP0786257A1 Tissue plasminogen activator glycosylation variants with improved therapeutic properties |
| 07/30/1997 | EP0786084A1 Method for screening compositions |
| 07/30/1997 | EP0786012A1 Enzymatic process for the preparation of chiral-alpha-tertiary carboxylic acid esters |
| 07/30/1997 | EP0786009A1 Process for bacterial production of heterologous polypeptides with disulphide bonds |
| 07/30/1997 | EP0786006A2 Cephalosporin c amidohydrolase, production and use |
| 07/30/1997 | EP0786004A1 Cloning, expression and characterisation of a novel form of phosphatidylinositol-3-kinase |
| 07/30/1997 | EP0786000A1 Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
| 07/30/1997 | EP0785999A1 Plant transcription regulators from circovirus |
| 07/30/1997 | EP0785995A1 A novel enzyme with beta-1,3-glucanase activity |
| 07/30/1997 | EP0785994A1 An enzyme with lipolytic activity |
| 07/30/1997 | EP0785992A1 Conditional transformation of genetically engineered cells |
| 07/30/1997 | EP0785989A1 Microbial synthesis of hiv protease inhibitors |
| 07/30/1997 | EP0785949A1 Method for purifying keratinocyte growth factors |
| 07/30/1997 | EP0785946A1 Materials for the production of nanometer structures and use thereof |
| 07/30/1997 | EP0785803A1 Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell |
| 07/30/1997 | EP0785786A1 Microbial synthesis of hiv protease inhibitors |
| 07/30/1997 | EP0785727A1 Preparation of frozen fermented foods using antifreeze polypeptide-expressing microorganisms |
| 07/30/1997 | EP0638114B1 Process for the desulfurization and the desalting of fossil fuels |
| 07/30/1997 | EP0604495B1 Secondary-metabolite biosynthesis genes from actinomycetes, method of isolating them, and their use |
| 07/30/1997 | CN1155904A LAG-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
| 07/30/1997 | CN1155830A A method of improving the quality of plant seeds |
| 07/29/1997 | US5652353 DNAs encoding tumor necrosis factor-α muteins |
| 07/29/1997 | US5652338 Neutrophil chemotactic factor |
| 07/29/1997 | US5652333 gC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies |
| 07/29/1997 | US5652223 DNA encoding CAI resistance proteins and uses thereof |
| 07/29/1997 | US5652217 Nucleotide sequence from staphylococcus aureus which codes for protein or polypeptide |
| 07/29/1997 | US5652135 Strains of bacillus and aerococcus as deterioration inhibitor for emulsion-type processing oil |
| 07/29/1997 | US5652132 Oxido reductase enzyme system obtainable from P. chrysogenum, the set of genes encoding the same and the use of oxido reductase enzyme systems or genes encoding the same for increasing antibiotic production |
| 07/29/1997 | US5652131 Cyclic GMP-binding, cyclic GMP-specific phosphodiesterase materials and methods |
| 07/29/1997 | US5652125 Process for preparing daunorubicin |
| 07/29/1997 | US5652123 Protein having interleukin 13 activity, recombinant DNA coding for this protein, transformed cells and microorganisms |
| 07/29/1997 | US5652120 Gene coding human epidermal growth factor and process for preparing the same |
| 07/29/1997 | US5652116 Method for genetically manipulating peptide synthetases |
| 07/29/1997 | US5652112 Assay for type I collagen carboxy-terminal telopeptide analytes |
| 07/29/1997 | US5652110 Antibodies to αvβ3 integrin |
| 07/29/1997 | US5652109 Antitumor agents; medical diagnosis |
| 07/29/1997 | US5652100 Stably transfected rodent fibroblast cell lines expressing human GABA-A -receptors |
| 07/29/1997 | US5652092 Amyloid precursor proteins and method of using same to assess agents which down-regulate formation of β-amyloid peptide |
| 07/29/1997 | CA1339113C Family of xanthan-based polysaccharide polymers including non-acetylatedand/or non-pyruvylated gum and acetylated or non-acetylated polytetramergum |